Key result
AxSYM assay yields falsely high BNP in 8 non-HF subjects versus Triage and Centaur assays.
Why the study?
Does the AxSYM assay produce falsely high BNP readings in patients without heart failure compared to other standard assays?
Case Report (n=8)
Does the AxSYM assay produce falsely high BNP readings in patients without heart failure compared to other standard assays?
The AxSYM assay may yield falsely high BNP levels in individuals without heart failure, highlighting the need for clinical correlation to avoid medical errors.
Answers are grounded in this paper and cite their sources.
Clinicians should correlate AxSYM BNP results with clinical findings; case report leaves open assay interference for validation.
We report a case series of eight subjects complaining of non-specific chest pain without heart failure, but with apparent high concentrations of plasma B-type natriuretic peptide (BNP). No positive clinical characteristics were identified in physical examinations, cardiac imaging, laboratory findings, or pulmonary function tests. However, we observed unusually high BNP values when analysing blood samples of the patients using the AxSYM assay, and this was not supported by readings from Triage® or ADVIA Centaur® assays on the same samples, which showed BNP within the normal range. We believe that the possibility for false readings for high BNP levels in healthy individuals measured by AxSYM assay should be taken into account by physicians in clinical practice to avoid medical errors.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2015) conducted a case report in Non-specific chest pain without heart failure (n=8). AxSYM assay vs. Triage® or ADVIA Centaur® assays was evaluated on BNP concentration. The AxSYM assay produced falsely high B-type natriuretic peptide (BNP) concentrations in 8 subjects without heart failure, whereas Triage and ADVIA Centaur assays showed normal ranges.
Synapse has enriched 10 related papers. Consider them for comparative context: